20 octubre 2014
A new drug in development may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia, scientists report. An estimated quarter of the 500 U.S. adolescents and young adults diagnosed each year with this aggressive disease fail to respond to standard chemotherapy drugs that target cancer cells.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/DgIr2NbJoKU/141020104750.htm
